In our current study of patients with SmRCC, patients with IMP3 positive tumors had inferior median OS; however this did not reach statistical significance presumably due to small sample size.
← all excerpts
Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma.
1
—
—